Compulsory licensing in Germany – the coronavirus crisis and beyond
Does not patenting COVID-19 vaccines help third world countries?
Available in Hungarian
Russian coronavirus vaccine – approval process in Hungary and the EU
Available in Hungarian
Pharmaceutical patent law in times of crisis: A comparative study – Part 2
by multiple authors
Pharmaceutical patent law in times of crisis: A comparative study – Part 1
by multiple authors
UK brand owners prejudiced at EUIPO by combination of COVID-19 and Brexit
COVID-19 and Patent Law
Q&A regarding compulsory licenses and governmental use
The EU moves towards a data-agile economy
by Mark Owen and Maria Luchian
COVID-19 postponement of MDR implementation date – how does this fit with Brexit?
COVID-19: Courts and IP offices in the Netherlands
by Dr. Wim Maas and Maarten Rijks